Anti-Müllerian hormone and ovarian aging

C. Tamer Erel,Ipek B. Ozcivit
DOI: https://doi.org/10.1080/09513590.2021.1977276
2021-09-14
Gynecological Endocrinology
Abstract:The ovary is the source of oocytes and supplier of sex steroid hormones. Being responsible for female fertility and endocrine homeostasis, the progressive decline in the quantity and quality of stromal cells in the ovary is defined as 'ovarian aging'. Understanding the mechanism of ovarian aging is of the utmost importance for the accurate assessment of ovarian reserve for fertility and timing of menopause [1]. Ovarian aging has a genetic basis, but it is affected by the environmental conditions of oxidative stress caused by mitochondrial dysfunction and chronic inflammation (i.e. due to smoking, radiation, chemicals and infections) [2]. Mitochondria, being the primary source of energy in cellular function, is the central site for reactive oxygen species (ROS) generation. They also have a key function in the rate of limiting step of steroidogenesis (steroidogenic acute regulatory (StAR) protein) and during oogenesis (oocyte maturation and function). Therefore, as a result of mitochondrial dysfunction (decrease in mitochondrial DNA (mtDNA) copy number, accumulation of mtDNA mutations, impaired oxidative phosphorylation activity and altered mitochondrial quality control), unbalanced oxidative stress has an important role in ovarian aging [2,3]. The reduced defense of antioxidant protective mechanisms against ROS results in oxidative damage. By the arrest in the cell cycle and apoptosis, it causes the loss of homeostasis and disturbs the maintenance of ovarian sex steroids and reserve, oocyte quality and viability. The link between mitochondria, inflammation and ovarian aging is important for the reproductive function.
endocrinology & metabolism,obstetrics & gynecology
What problem does this paper attempt to address?